These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
838 related items for PubMed ID: 18029445
1. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice. Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH. Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445 [Abstract] [Full Text] [Related]
2. Nutritional regulation of adipose tissue apolipoprotein E expression. Huang ZH, Luque RM, Kineman RD, Mazzone T. Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E203-9. PubMed ID: 17389709 [Abstract] [Full Text] [Related]
3. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ. Biochem Biophys Res Commun; 2004 Apr 23; 317(1):223-9. PubMed ID: 15047172 [Abstract] [Full Text] [Related]
4. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Hechler B, Freund M, Ravanat C, Magnenat S, Cazenave JP, Gachet C. Circulation; 2008 Aug 12; 118(7):754-63. PubMed ID: 18663083 [Abstract] [Full Text] [Related]
5. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Taleb S, Herbin O, Ait-Oufella H, Verreth W, Gourdy P, Barateau V, Merval R, Esposito B, Clément K, Holvoet P, Tedgui A, Mallat Z. Arterioscler Thromb Vasc Biol; 2007 Dec 12; 27(12):2691-8. PubMed ID: 17690315 [Abstract] [Full Text] [Related]
6. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr. Lloyd DJ, McCormick J, Helmering J, Kim KW, Wang M, Fordstrom P, Kaufman SA, Lindberg RA, Véniant MM. Am J Physiol Endocrinol Metab; 2008 Mar 12; 294(3):E496-505. PubMed ID: 18160459 [Abstract] [Full Text] [Related]
10. VLDL induces adipocyte differentiation in ApoE-dependent manner. Chiba T, Nakazawa T, Yui K, Kaneko E, Shimokado K. Arterioscler Thromb Vasc Biol; 2003 Aug 01; 23(8):1423-9. PubMed ID: 12842848 [Abstract] [Full Text] [Related]
11. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice. Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y. J Pharm Pharmacol; 2006 Dec 01; 58(12):1629-38. PubMed ID: 17331327 [Abstract] [Full Text] [Related]
17. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice. Potteaux S, Combadière C, Esposito B, Lecureuil C, Ait-Oufella H, Merval R, Ardouin P, Tedgui A, Mallat Z. Arterioscler Thromb Vasc Biol; 2006 Aug 01; 26(8):1858-63. PubMed ID: 16763157 [Abstract] [Full Text] [Related]